THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING
Life Sciences: Biotech

Cells, not tools, may help fix arteries

Start-up gets $15m to test new method

By Stephen Heuser
Globe Staff / October 2, 2006

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In the past decade, artery repair has become one of the most lucrative industries in healthcare, spawning billion-dollar companies like Boston Scientific Corp. that make equipment to keep blood flowing smoothly through the body's most important vessels. (Full article: 850 words)

This article is available in our archives:

Globe Subscribers

FREE for subscribers

Subscribers to the Boston Globe get unlimited access to our archives.

Not a subscriber?

Non-Subscribers

Purchase an electronic copy of the full article. Learn More

  • $9.95 1 month archives pass
  • $24.95 3 months archives pass
  • $74.95 1 year archives pass